Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3394
Abstract: An increasing number of patients undergo contralateral prophylactic mastectomy (CPM) for unilateral breast cancer. However, the benefit of CPM has not been quantified in the setting of contemporary breast cancer therapy. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-021-06105-x
Abstract: Iowa is among several rural Midwestern states with the highest proportions of contralateral prophylactic mastectomy (CPM) in women < 45 years of age. We evaluated the role of rurality and travel distance in these surgical… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Current Breast Cancer Reports"
DOI: 10.1007/s12609-019-00338-y
Abstract: Contralateral prophylactic mastectomy (CPM) at the time of unilateral breast cancer surgery is increasing, though still controversial in BRCA(−) patients. We review the relevant literature regarding CPM and specifically abnormal imaging/biopsies in patients following unilateral… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Breast"
DOI: 10.1016/j.breast.2016.11.025
Abstract: OBJECTIVES Contralateral prophylactic mastectomy (CPM) reduces the risk of contralateral breast cancer (BC) following unilateral BC, but may not increase survival in BRCA1/2 mutation negative women. Despite this, and the risk for adverse physical and… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Surgery"
DOI: 10.1016/j.surg.2018.05.038
Abstract: Background: We sought to determine whether patients undergoing contralateral, prophylactic mastectomy have greater anticipated and actual costs and financial burden than patients undergoing unilateral mastectomy, whether these financial considerations influence surgical decision making, and whether… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of women's health"
DOI: 10.1089/jwh.2018.7350
Abstract: BACKGROUND Contralateral prophylactic mastectomy (CPM) treatments have been on the rise among white women with early stage unilateral breast cancer who have a higher socioeconomic status (SES) and private insurance. Low income and uninsured women… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Translational behavioral medicine"
DOI: 10.1093/tbm/ibz006
Abstract: Women with sporadic breast cancer should consider unilateral surgery as first choice for local treatment. Contralateral prophylactic mastectomy should be offered to patients with BRCA mutation. read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Medical Humanities"
DOI: 10.1136/medhum-2022-012460
Abstract: Contralateral prophylactic mastectomy (CPM) is a controversial breast cancer treatment in which both breasts are removed when only one is affected by cancer. Rates of CPM have been rising since the late 1990s, despite surgeons’… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Women's Health"
DOI: 10.1177/17455057231175812
Abstract: Contralateral prophylactic mastectomy is the removal of both breasts when only one is affected by cancer. Rates of this controversial cancer treatment have been increasing since the late 1990s, even among women who do not… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-019-07883-x
Abstract: The rate of contralateral prophylactic mastectomy in women with unilateral average-risk breast cancer has increased significantly in the past decade. Our study was conducted in response to a recently published position statement from the American… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Canadian Journal of Surgery"
DOI: 10.1503/cjs.003420
Abstract: Background: Rates of contralateral prophylactic mastectomy (CPM) are increasing among women with unilateral breast cancer despite low rates of contralateral recurrence and lack of survival benefit. We aimed to investigate the decisional needs and supports… read more here.